
Join to View Full Profile
100 Stein PlzLos Angeles, CA 90095
Phone+1 310-473-8878
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Louis Chang, MD is a board certified ophthalmologist in Los Angeles, California. He is currently licensed to practice medicine in California and New York.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2004 - 2007
- Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 2003 - 2004
- Washington University in St. Louis School of MedicineClass of 2003
- University of Washington School of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2013 - 2026
- NY State Medical License 2007 - 2014
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 20 citationsHemi- and Central Retinal Vein Occlusion Associated with COVID-19 Infection in Young Patients without Known Risk Factors.Noy Ashkenazy, Nimesh A Patel, Jayanth Sridhar, Nicolas A Yannuzzi, Peter J Belin
Ophthalmology. Retina. 2022-06-01 - 13 citationsProphylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial.Clement K Chan, Maziar Lalezary, Prema Abraham, Michael Elman, Wesley Thomas Beaulieu
Ophthalmology. Retina. 2022-06-01 - 22 citationsHemi-retinal vein occlusion in a young patient with COVID-19Avni P. Finn, Rahul N. Khurana, Louis K. Chang
American Journal of Ophthalmology Case Reports. 2021-03-05
Press Mentions
- Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal UseOctober 7th, 2020